Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of two doses of
dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD
(MPH) and placebo in children ages 6-12 diagnosed with ADHD.